<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Trials</journal-id><journal-title>Trials</journal-title><issn pub-type="epub">1745-6215</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">16677402</article-id><article-id pub-id-type="pmc">1479366</article-id><article-id pub-id-type="publisher-id">1745-6215-7-12</article-id><article-id pub-id-type="doi">10.1186/1745-6215-7-12</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>Duodenum preserving pancreatectomy in chronic pancreatitis: Design of a randomized controlled trial comparing two surgical techniques [ISRCTN50638764]</article-title></title-group><contrib-group><contrib id="A1" equal-contrib="yes" contrib-type="author"><name><surname>Köninger</surname><given-names>Jörg</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>joerg.koeninger@med.uni-heidelberg.de</email></contrib><contrib id="A2" equal-contrib="yes" contrib-type="author"><name><surname>Seiler</surname><given-names>Christoph M</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>christoph.seiler@med.uni-heidelberg.de</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Wente</surname><given-names>Moritz N</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>moritz.wente@med.uni-heidelberg.de</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Reidel</surname><given-names>Margot A</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>margot.reidel@med.uni-heidelberg.de</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Gazyakan</surname><given-names>Emre</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>gazyakan@bgu-ludwigshafen.de</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Mansmann</surname><given-names>Ulrich</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>mansmann@ibe.uni-muenchen.de</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Müller</surname><given-names>Michael W</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>michael.mueller@med.uni-heidelberg.de</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Friess</surname><given-names>Helmut</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>helmut.friess@med.uni-heidelberg.de</email></contrib><contrib id="A9" corresp="yes" contrib-type="author"><name><surname>Büchler</surname><given-names>Markus W</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>markus.buechler@med.uni-heidelberg.de</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of General Surgery, University of Heidelberg, Germany</aff><aff id="I2"><label>2</label>Department of General Surgery, Center for Clinical Studies, University of Heidelberg, Germany</aff><aff id="I3"><label>3</label>Institute for Medical Biometrics and Informatics, University of Heidelberg, Germany</aff><pub-date pub-type="collection"><year>2006</year></pub-date><pub-date pub-type="epub"><day>8</day><month>5</month><year>2006</year></pub-date><volume>7</volume><fpage>12</fpage><lpage>12</lpage><ext-link ext-link-type="uri" xlink:href="http://www.trialsjournal.com/content/7/1/12"></ext-link><history><date date-type="received"><day>18</day><month>4</month><year>2006</year></date><date date-type="accepted"><day>8</day><month>5</month><year>2006</year></date></history><permissions><copyright-statement>Copyright © 2006 Köninger et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2006</copyright-year><copyright-holder>Köninger et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"></ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><sec><title><offsets xml_i="4579" xml_f="4589" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="4600" xml_f="5284" txt_i="22" txt_f="706">Chronic pancreatitis is an inflammatory disease which is characterized by an irreversible conversion of pancreatic parenchyma to fibrous tissue. Beside obstructive jaundice and pseudocyst formation, about half of the patients need surgical intervention due to untreatable chronic pain during the course of the disease. In most of the patients with chronic pancreatitis, the head of the pancreas is the trigger of the chronic inflammatory process. Therefore, resection of pancreatic head tissue must be the central part of any surgical intervention. However, it is unclear to which extent the surgical procedure must be radical in order to obtain a favourable outcome for the patients.</offsets></p></sec><sec><title><offsets xml_i="5306" xml_f="5312" txt_i="708" txt_f="714">Design</offsets></title><p><offsets xml_i="5323" xml_f="6138" txt_i="715" txt_f="1530">A single centre randomized controlled, superiority trial to compare two techniques of duodenum preserving pancreatic head resection. Sample size: 65 patients will be included and randomized intraoperatively. Eligibility criteria: All patients with chronic pancreatitis and indication for surgical resection and signed informed consent. Cumulative primary endpoint (hierarchical model): duration of surgical procedure, quality of life after one year, duration of intensive care unit stay, duration of hospital stay. Reference treatment: Resection of the pancreatic head with dissection of the pancreas from the portal vein and transsection of the gland (Beger procedure). Intervention: Partial Resection of the pancreatic head without transsection of the organ and visualization of the portal vein (Berne procedure).</offsets></p><p><offsets xml_i="6145" xml_f="6183" txt_i="1531" txt_f="1569">Duration: September 2003-October 2007.</offsets></p></sec><sec><title><offsets xml_i="6205" xml_f="6232" txt_i="1571" txt_f="1598">Organisation/responsibility</offsets></title><p><offsets xml_i="6243" xml_f="6647" txt_i="1599" txt_f="2003">The trial is conducted in compliance with the protocol and in accordance with the moral, ethical, regulatory and scientific principles governing clinical research as set out in the Declaration of Helsinki (1989) and the Good Clinical Practice guideline (GCP). The Center for Clinical Studies of the Department of Surgery Heidelberg is responsible for planning, conducting and final analysis of the trial.</offsets></p></sec></abstract></article-meta></front><body><sec><title><offsets xml_i="6709" xml_f="6719" txt_i="2012" txt_f="2022">Background</offsets></title><sec><title><offsets xml_i="6739" xml_f="6754" txt_i="2023" txt_f="2038">Medical problem</offsets></title><p><offsets xml_i="6765" xml_f="7074" txt_i="2039" txt_f="2348">Chronic pancreatitis is an inflammatory disease, which is characterized by progressive and irreversible destruction of pancreatic parenchyma and transformation into fibrous tissue. The leading symptom of chronic pancreatitis is chronic pain, which requires surgical intervention in about 50% of the patients [</offsets><xref ref-type="bibr" rid="B1"><offsets xml_i="7105" xml_f="7106" txt_i="2348" txt_f="2349">1</offsets></xref><offsets xml_i="7113" xml_f="7115" txt_i="2349" txt_f="2351">].</offsets></p><p><offsets xml_i="7122" xml_f="7466" txt_i="2352" txt_f="2696">Despite of the fact that the etiopathogenesis of pain in chronic pancreatitis is not fully understood, the concept of a neuroimmune interaction in the head of the pancreas is in accordance with the observation that simple drainage procedures seldom lead to satisfactory pain relief in the long run in patients with an enlarged pancreatic head [</offsets><xref ref-type="bibr" rid="B2"><offsets xml_i="7497" xml_f="7498" txt_i="2696" txt_f="2697">2</offsets></xref><offsets xml_i="7505" xml_f="7506" txt_i="2697" txt_f="2698">-</offsets><xref ref-type="bibr" rid="B6"><offsets xml_i="7537" xml_f="7538" txt_i="2698" txt_f="2699">6</offsets></xref><offsets xml_i="7545" xml_f="7706" txt_i="2699" txt_f="2860">]. Only surgical techniques that include resection of the inflammatory mass in the pancreatic head have shown to be successful in the treatment of this disease [</offsets><xref ref-type="bibr" rid="B7"><offsets xml_i="7737" xml_f="7738" txt_i="2860" txt_f="2861">7</offsets></xref><offsets xml_i="7745" xml_f="7746" txt_i="2861" txt_f="2862">,</offsets><xref ref-type="bibr" rid="B8"><offsets xml_i="7777" xml_f="7778" txt_i="2862" txt_f="2863">8</offsets></xref><offsets xml_i="7785" xml_f="7787" txt_i="2863" txt_f="2865">].</offsets></p></sec><sec><title><offsets xml_i="7809" xml_f="7850" txt_i="2867" txt_f="2908">The Beger procedure (reference treatment)</offsets></title><p><offsets xml_i="7861" xml_f="8023" txt_i="2909" txt_f="3071">In 1972, H.G. Beger for the first time described the technique of duodenum preserving pancreatectomy in the treatment of patients with chronic pancreatitis (Fig. </offsets><xref ref-type="fig" rid="F1"><offsets xml_i="8053" xml_f="8054" txt_i="3071" txt_f="3072">1</offsets></xref><offsets xml_i="8061" xml_f="8064" txt_i="3072" txt_f="3075">) [</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="8095" xml_f="8096" txt_i="3075" txt_f="3076">9</offsets></xref><offsets xml_i="8103" xml_f="8104" txt_i="3076" txt_f="3077">,</offsets><xref ref-type="bibr" rid="B10"><offsets xml_i="8136" xml_f="8138" txt_i="3077" txt_f="3079">10</offsets></xref><offsets xml_i="8145" xml_f="8653" txt_i="3079" txt_f="3584">]. The rationale of this intervention is the resection of the inflammatory mass in the pancreatic head without large loss of unaffected parenchyma and maintenance of the duodenal passage. Different studies have shown that this organ preserving technique is at least as effective as the more radical Kausch-Whipple procedure (pancreatico-duodenectomy) regarding pain control (effective pain diminishing in &gt;80% within 5 years), but postoperative morbidity and the incidence of diabetes mellitus are lower [</offsets><xref ref-type="bibr" rid="B1"><offsets xml_i="8684" xml_f="8685" txt_i="3584" txt_f="3585">1</offsets></xref><offsets xml_i="8692" xml_f="8693" txt_i="3585" txt_f="3586">,</offsets><xref ref-type="bibr" rid="B11"><offsets xml_i="8725" xml_f="8727" txt_i="3586" txt_f="3588">11</offsets></xref><offsets xml_i="8734" xml_f="8735" txt_i="3588" txt_f="3589">-</offsets><xref ref-type="bibr" rid="B13"><offsets xml_i="8767" xml_f="8769" txt_i="3589" txt_f="3591">13</offsets></xref><offsets xml_i="8776" xml_f="8778" txt_i="3591" txt_f="3593">].</offsets></p><fig position="float" id="F1"><label><offsets xml_i="8819" xml_f="8827" txt_i="3594" txt_f="3602">Figure 1</offsets></label><caption><p><bold><offsets xml_i="8853" xml_f="8890" txt_i="3602" txt_f="3639">Beger procedure (reference treatment)</offsets></bold><offsets xml_i="8897" xml_f="9052" txt_i="3639" txt_f="3794">. Reconstruction after duodenum preserving pancreatic head resection with a Roux en-Y jejunal loop as side-to-end and side-to-side pancreatico-jejunostomy.</offsets></p></caption><graphic xlink:href="1745-6215-7-12-1"></graphic></fig></sec><sec><title><offsets xml_i="9139" xml_f="9186" txt_i="3796" txt_f="3843">The Berne procedure (selection of intervention)</offsets></title><p><offsets xml_i="9197" xml_f="9449" txt_i="3844" txt_f="4096">Over the years, different variations of the duodenum preserving technique have been introduced. In 1985, Frey and Smith described a modification in which a longitudinal pancreatico-jejunostomy is combined with a local resection of the pancreatic head [</offsets><xref ref-type="bibr" rid="B14"><offsets xml_i="9481" xml_f="9483" txt_i="4096" txt_f="4098">14</offsets></xref><offsets xml_i="9490" xml_f="9491" txt_i="4098" txt_f="4099">,</offsets><xref ref-type="bibr" rid="B15"><offsets xml_i="9523" xml_f="9525" txt_i="4099" txt_f="4101">15</offsets></xref><offsets xml_i="9532" xml_f="10167" txt_i="4101" txt_f="4736">]. This technique combines the principle of duodenum preserving pancreatic head resection with the drainage of the main pancreatic duct. In 1998, similar to the Frey technique, Izbicki et al. combined the duodenum preserving resection of the pancreatic head with a V-shaped incision of the body of the pancreas in order to also reach II° and III° pancreatic side branches. The results obtained with this technique are very similar to the original Beger technique. Thirty patients were operated without mortality. After a median follow up of 30 months, 92% of the patients were pain free with preserved endocrine and exocrine function [</offsets><xref ref-type="bibr" rid="B16"><offsets xml_i="10199" xml_f="10201" txt_i="4736" txt_f="4738">16</offsets></xref><offsets xml_i="10208" xml_f="10210" txt_i="4738" txt_f="4740">].</offsets></p><p><offsets xml_i="10217" xml_f="10444" txt_i="4741" txt_f="4968">The main advantage of these variations of the original Beger procedure lies in the fact that the dissection of the pancreas from the portal vein can be avoided, which is regarded as the most hazardous part of the intervention [</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="10475" xml_f="10476" txt_i="4968" txt_f="4969">4</offsets></xref><offsets xml_i="10483" xml_f="10776" txt_i="4969" txt_f="5262">]. Especially in case of portal vein thrombosis, the division of the pancreatic body from the portal vein, which is an essential step in the Beger (and also Kausch-Whipple) procedure, can be very demanding. Bleeding from the portal vein in this situation can be extremely difficult to control.</offsets></p><p><offsets xml_i="10783" xml_f="11213" txt_i="5263" txt_f="5693">To combine the advantages of the original Beger procedure with the Frey technique, we developed an additional modification which consists in a duodenum preserving resection of the pancreatic head in analogy to the original Beger technique, with the difference that a small shape of pancreatic tissue remains on the anterior wall of the portal vein in a way that the hazardous division of vein and pancreatic body is avoided (Fig. </offsets><xref ref-type="fig" rid="F2"><offsets xml_i="11243" xml_f="11244" txt_i="5693" txt_f="5694">2</offsets></xref><offsets xml_i="11251" xml_f="11254" txt_i="5694" txt_f="5697">) [</offsets><xref ref-type="bibr" rid="B17"><offsets xml_i="11286" xml_f="11288" txt_i="5697" txt_f="5699">17</offsets></xref><offsets xml_i="11295" xml_f="11297" txt_i="5699" txt_f="5701">].</offsets></p><fig position="float" id="F2"><label><offsets xml_i="11338" xml_f="11346" txt_i="5702" txt_f="5710">Figure 2</offsets></label><caption><p><bold><offsets xml_i="11372" xml_f="11402" txt_i="5710" txt_f="5740">Berne procedure (intervention)</offsets></bold><offsets xml_i="11409" xml_f="11548" txt_i="5740" txt_f="5879">. Reconstruction after duodenum preserving pancreatic head resection with a Roux en-Y jejunal loop as side-to-side pancreatico-jejunostomy.</offsets></p></caption><graphic xlink:href="1745-6215-7-12-2"></graphic></fig></sec></sec><sec><title><offsets xml_i="11641" xml_f="11653" txt_i="5882" txt_f="5894">Study design</offsets></title><sec><title><offsets xml_i="11673" xml_f="11689" txt_i="5895" txt_f="5911">Aim of the study</offsets></title><p><offsets xml_i="11700" xml_f="11994" txt_i="5912" txt_f="6206">The objective of this trial is to compare two different surgical techniques for the treatment of chronic pancreatitis with regard to complication rates, length of operation, length of intensive care treatment, length of hospital stay, exocrine/endocrine pancreatic function and quality of life.</offsets></p></sec><sec><title><offsets xml_i="12016" xml_f="12041" txt_i="6208" txt_f="6233">Number of patients needed</offsets></title><p><offsets xml_i="12052" xml_f="12425" txt_i="6234" txt_f="6607">As estimated effect size a difference of mean operating time of one hour between the two groups and a variability of this difference in between the expected absolute effect (standard deviation of one hour) is defined. Groups of 22 patients each would permit the verification of the null-hypothesis with an α-error set at 0.05 and a β-error at 0.10, yielding a power of 90%.</offsets></p><p><offsets xml_i="12432" xml_f="12842" txt_i="6608" txt_f="7018">To evaluate the true efficacy of the Berne procedure a per protocol analysis is necessary. For the external validity of the study an intention to treat approach for analysis is requested. Due to the nature of complex surgery such as a pancreatic resection it can be expected that one third of all randomised patients will not receive the intended procedure. Therefore at least 65 patients should be randomised.</offsets></p></sec></sec><sec><title><offsets xml_i="12870" xml_f="12890" txt_i="7021" txt_f="7041">Eligibility criteria</offsets></title><sec><title><offsets xml_i="12910" xml_f="12928" txt_i="7042" txt_f="7060">Inclusion criteria</offsets></title><p><offsets xml_i="12939" xml_f="12972" txt_i="7061" txt_f="7091">• Patients of any age (&gt;18 ys)</offsets></p><p><offsets xml_i="12979" xml_f="13023" txt_i="7092" txt_f="7136">• Expected survival time more than 24 months</offsets></p><p><offsets xml_i="13030" xml_f="13048" txt_i="7137" txt_f="7155">• Informed consent</offsets></p></sec><sec><title><offsets xml_i="13070" xml_f="13088" txt_i="7157" txt_f="7175">Exclusion criteria</offsets></title><p><offsets xml_i="13099" xml_f="13213" txt_i="7176" txt_f="7290">• Participation in another intervention trial that would interfere with the intervention and outcome of this study</offsets></p><p><offsets xml_i="13220" xml_f="13275" txt_i="7291" txt_f="7346">• Severe psychiatric disorders or neurological diseases</offsets></p><p><offsets xml_i="13282" xml_f="13302" txt_i="7347" txt_f="7367">• Lack of compliance</offsets></p><p><offsets xml_i="13309" xml_f="13365" txt_i="7368" txt_f="7424">• Drug and/or alcohol abuse according to local standards</offsets></p></sec><sec><title><offsets xml_i="13387" xml_f="13425" txt_i="7426" txt_f="7464">Ethics, study registration and consent</offsets></title><p><offsets xml_i="13436" xml_f="13942" txt_i="7465" txt_f="7971">The final protocol was approved by the independent ethics committee of the University of Heidelberg. The study was registered at Current Clinical Trials (ISRCTN No. 50638764). Patients who are scheduled for duodenum preserving pancreatic head resection had a pre-treatment visit to give the informed consent. During this visit the patient will be screened and informed about the trial. In the course of the conversation, the study procedure, risks, benefits and data management will be clarified in detail.</offsets></p></sec></sec><sec><title><offsets xml_i="13970" xml_f="14018" txt_i="7974" txt_f="8022">Randomisation and procedures for minimising bias</offsets></title><sec><title><offsets xml_i="14038" xml_f="14064" txt_i="8023" txt_f="8049">Minimising systematic bias</offsets></title><p><offsets xml_i="14075" xml_f="14276" txt_i="8050" txt_f="8251">In order to achieve comparable groups for known and unknown risk factors, randomization will be performed. The random allocation sequence was generated by a free available randomization software tool [</offsets><xref ref-type="bibr" rid="B18"><offsets xml_i="14308" xml_f="14310" txt_i="8251" txt_f="8253">18</offsets></xref><offsets xml_i="14317" xml_f="15141" txt_i="8253" txt_f="9077">] by a trained independent study nurse not further involved in this trial. She also prepared the sealed and opaque envelopes for the randomisation procedure in the operation theatre. The sealed randomization list was stored in the investigator file. A sufficient number of patients will be recruited according to the sample size calculation in order to prevent random error. Patients will get randomised intra-operatively by an independent study nurse or anaesthesiologist once the surgeon decides that clinical equipoise is given, usually after the pancreas has been prepared and mobilised (Kocher's maneuver). All interventions will be done as described below. Patients in whom the randomised procedure cannot be performed due to technical or anatomical reasons will be analysed according the intention to treat principle.</offsets></p></sec><sec><title><offsets xml_i="15163" xml_f="15188" txt_i="9079" txt_f="9104">Minimising treatment bias</offsets></title><p><offsets xml_i="15199" xml_f="15653" txt_i="9105" txt_f="9559">The participating surgeons are all experienced in pancreatic surgery. Annually more than 300 resections of the pancreas are performed in Heidelberg. Both procedures used in this trial are supervised by two authors (H.F., M.W.B.) in order to guarantee correct execution according to the protocol (intraoperative surgical monitoring). Concomitant treatment will be equal for both groups including antibiotic prophylaxis, use of sandostatin and anaesthesia.</offsets></p></sec><sec><title><offsets xml_i="15675" xml_f="15702" txt_i="9561" txt_f="9588">Minimising measurement bias</offsets></title><p><offsets xml_i="15713" xml_f="15887" txt_i="9589" txt_f="9763">An independent study nurse will document and monitor the procedure in the operating theatre. Blinding in this phase of the trial is not possible due to the research question.</offsets></p><p><offsets xml_i="15894" xml_f="16110" txt_i="9764" txt_f="9980">Standardized patient interviews will be performed by blinded study nurses 6, 12 and 24 months after surgery, using EORTC QLQ-C30 questionnaire and the disease specific module for pancreatic diseases EORTC QLQ-PAN26 [</offsets><xref ref-type="bibr" rid="B19"><offsets xml_i="16142" xml_f="16144" txt_i="9980" txt_f="9982">19</offsets></xref><offsets xml_i="16151" xml_f="16152" txt_i="9982" txt_f="9983">,</offsets><xref ref-type="bibr" rid="B20"><offsets xml_i="16184" xml_f="16186" txt_i="9983" txt_f="9985">20</offsets></xref><offsets xml_i="16193" xml_f="16195" txt_i="9985" txt_f="9987">].</offsets></p></sec></sec><sec><title><offsets xml_i="16223" xml_f="16238" txt_i="9990" txt_f="10005">Study treatment</offsets></title><p><offsets xml_i="16249" xml_f="16588" txt_i="10006" txt_f="10345">After a midline laparotomy, wide exposure of the pancreas is obtained by opening of the gastro-colic ligament. The duodenum and the pancreatic head are then mobilized by an extended Kocher maneuver. If there are any doubts on the dignity of the pancreatic head tumour, biopsies will be taken and pathological examination will be performed.</offsets></p><p><offsets xml_i="16595" xml_f="16781" txt_i="10346" txt_f="10532">After exhibition of the pancreas, the randomisation will be performed using sequentially numbered, opaque, sealed envelopes; according to the allocation, the procedure will be continued.</offsets></p><sec><title><offsets xml_i="16797" xml_f="16834" txt_i="10533" txt_f="10570">Beger procedure (reference treatment)</offsets></title><p><offsets xml_i="16845" xml_f="17828" txt_i="10571" txt_f="11554">The pancreas is gently lifted and subtle dissection is performed between the mesenteric vein and the body of the pancreas, taking care to avoid injury to the major retropancreatic vessels and smaller side branches. After this step, multiple stay sutures (4/0 PDS) are placed around the parenchyma of the pancreatic head to assign resection margins. This is important to avoid inadvertent injury to the duodenum and assures that a lamella of pancreatic parenchyma along the loop of the duodenum remains and assures blood supply. The subtotal resection of the pancreatic head starts with the transsection of the pancreas above the portal vein proceeding towards the prepapillary common bile duct. In all phases of the intervention meticulous haemostasis is required. Reconstruction is performed with a Roux-en-Y loop of the jejunum with an end-to-side pancreatico-jejunal anastomosis and another side-to-side anastomosis of the jejunal loop with the remaining hollowed pancreatic head.</offsets></p></sec><sec><title><offsets xml_i="17850" xml_f="17890" txt_i="11556" txt_f="11596">Berne procedure (intervention treatment)</offsets></title><p><offsets xml_i="17901" xml_f="18380" txt_i="11597" txt_f="12076">Both the dissection of the pancreatic body from the portal vein and the transsection of the pancreas over the portal vein is not done with the consequence that only one cavity results. Also in this case, multiple stay sutures mark the dissection margin and support blood sparing surgery. After subtotal resection of the pancreatic head, reconstruction is performed in analogy to the original Beger-technique with a Roux-en-Y jejunal loop and side-to-side pancreatico-jejunostomy.</offsets></p><p><offsets xml_i="18387" xml_f="18741" txt_i="12077" txt_f="12431">Independently of the type of resection (Beger or Berne procedure), in case of stenosis of the intrapancreatic segment of the common bile duct which cannot be decompressed by resecting the circumferential fibrous tissue or in case of accidental opening of the common bile duct during resection, an additional bilio-digestive anastomosis will be performed.</offsets></p></sec></sec><sec><title><offsets xml_i="18769" xml_f="18800" txt_i="12434" txt_f="12465">Primary and secondary endpoints</offsets></title><sec><title><offsets xml_i="18820" xml_f="18837" txt_i="12466" txt_f="12483">Primary endpoints</offsets></title><p><offsets xml_i="18848" xml_f="18974" txt_i="12484" txt_f="12610">The primary endpoint is combined out of four components. In order to adjust for multiple testing a hierarchical model is used.</offsets></p><p><offsets xml_i="18981" xml_f="19020" txt_i="12611" txt_f="12650">1. Duration of surgical procedure [min]</offsets></p><p><offsets xml_i="19027" xml_f="19183" txt_i="12651" txt_f="12807">2. Quality of life (EORTC QLQ-C30 questionnaire and the disease specific module for pancreatic diseases EORTC QLQ-PAN26) at 12 months after the intervention</offsets></p><p><offsets xml_i="19190" xml_f="19236" txt_i="12808" txt_f="12854">3. Duration of stay on the intensive care unit</offsets></p><p><offsets xml_i="19243" xml_f="19285" txt_i="12855" txt_f="12897">4. Duration of postoperative hospital stay</offsets></p></sec><sec><title><offsets xml_i="19307" xml_f="19326" txt_i="12899" txt_f="12918">Secondary endpoints</offsets></title><p><offsets xml_i="19337" xml_f="19662" txt_i="12919" txt_f="13244">Frequencies of early and late onset complications such as intra- or postoperative bleeding with subsequent need for blood transfusion, pancreatic fistula, postoperative pulmonary complications, wound infections and re-laparotomy; exocrine and endocrine pancreatic function as determined by levels of HbA1c and stool elastase.</offsets></p></sec></sec><sec><title><offsets xml_i="19690" xml_f="19731" txt_i="13247" txt_f="13288">Adverse events and serious adverse events</offsets></title><p><offsets xml_i="19742" xml_f="19751" txt_i="13289" txt_f="13298">The term </offsets><italic><offsets xml_i="19759" xml_f="19773" txt_i="13298" txt_f="13312">adverse event </offsets></italic><offsets xml_i="19782" xml_f="20109" txt_i="13312" txt_f="13639">(AE) covers any sign, symptom, syndrome, or illness that appears or worsens in a patient during the period of observation in the clinical trial and that may impair the well-being of the patient. The term also covers laboratory findings or results of other diagnostic procedures that are considered to be clinically relevant. A </offsets><italic><offsets xml_i="20117" xml_f="20145" txt_i="13639" txt_f="13667">serious adverse event (SAE) </offsets></italic><offsets xml_i="20154" xml_f="20391" txt_i="13667" txt_f="13904">is any adverse event that occurs at any time during the period of observation that results in death, is immediately life-threatening, requires or prolongs hospitalization, or results in persistent or significant disability or incapacity.</offsets></p><p><offsets xml_i="20398" xml_f="20491" txt_i="13905" txt_f="13998">AEs will be reported to the principle investigator in regular intervals throughout the study.</offsets></p><p><offsets xml_i="20498" xml_f="20690" txt_i="13999" txt_f="14191">SAEs which are meet one of definitions of the secondary endpoints are treated as SAEs regarding to documentation, but have not to be reported to the sponsor/principle investigator within 24 h.</offsets></p></sec><sec><title><offsets xml_i="20712" xml_f="20720" txt_i="14193" txt_f="14201">Analysis</offsets></title><p><offsets xml_i="20731" xml_f="20792" txt_i="14202" txt_f="14263">A flow chart according to the CONSORT statement is included [</offsets><xref ref-type="bibr" rid="B21"><offsets xml_i="20824" xml_f="20826" txt_i="14263" txt_f="14265">21</offsets></xref><offsets xml_i="20833" xml_f="20917" txt_i="14265" txt_f="14349">]. The baseline characteristics of patients in both groups will be given in a table.</offsets></p><p><offsets xml_i="20924" xml_f="21209" txt_i="14350" txt_f="14635">Comparisons will be made of the primary endpoints of both intervention groups for all patients included in the study on an intention to treat basis. Furthermore per protocol analysis will be performed as well as including only patients strictly treated according to the study protocol.</offsets></p><p><offsets xml_i="21216" xml_f="21334" txt_i="14636" txt_f="14754">The outcome measures of the primary endpoint will be tested for significance with the Mann-Whitney Test (The test of H</offsets><sub><offsets xml_i="21339" xml_f="21343" txt_i="14754" txt_f="14758">0,1 </offsets></sub><offsets xml_i="21349" xml_f="21352" txt_i="14758" txt_f="14761">no </offsets><italic><offsets xml_i="21360" xml_f="21409" txt_i="14761" txt_f="14810">difference of duration of the surgical procedure </offsets></italic><offsets xml_i="21418" xml_f="21568" txt_i="14810" txt_f="14960">on the level of 5%). If the null hypothesis of no difference can be rejected the other components can be tested in a hierarchical way as follows (Fig </offsets><xref ref-type="fig" rid="F3"><offsets xml_i="21598" xml_f="21599" txt_i="14960" txt_f="14961">3</offsets></xref><offsets xml_i="21606" xml_f="21608" txt_i="14961" txt_f="14963">):</offsets></p><fig position="float" id="F3"><label><offsets xml_i="21649" xml_f="21657" txt_i="14964" txt_f="14972">Figure 3</offsets></label><caption><p><bold><offsets xml_i="21683" xml_f="21693" txt_i="14972" txt_f="14982">Flow chart</offsets></bold><offsets xml_i="21700" xml_f="21815" txt_i="14982" txt_f="15097">. If the null hypothesis of no difference can be rejected the other components can be tested in a hierarchical way.</offsets></p></caption><graphic xlink:href="1745-6215-7-12-3"></graphic></fig><p><offsets xml_i="21887" xml_f="21903" txt_i="15098" txt_f="15114">1. The test of H</offsets><sub><offsets xml_i="21908" xml_f="21912" txt_i="15114" txt_f="15118">0,2 </offsets></sub><italic><offsets xml_i="21926" xml_f="21975" txt_i="15118" txt_f="15167">Quality of life in both groups is not equivalent </offsets></italic><offsets xml_i="21984" xml_f="22116" txt_i="15167" txt_f="15299">is an equivalence test. Based on preliminary experiences with the EORTC QLQ-C30/PAN26 questionnaires in pancreatic cancer patients [</offsets><xref ref-type="bibr" rid="B20"><offsets xml_i="22148" xml_f="22150" txt_i="15299" txt_f="15301">20</offsets></xref><offsets xml_i="22157" xml_f="22971" txt_i="15301" txt_f="16115">], we estimated baseline raw score values in the range of about 60 (SD 25) before therapy. When transformed into a percentage scale (with 100% indicating perfect health) this represents values of 45% (SD 18%). After surgery, quality of life can be estimated to improve up to value of 75% (SD 18%). We assume equivalence for the two resection techniques, if the two-sided 95% confidence intervals for difference in quality of life fall within the interval of +/-15%. The value of 15 as delta was chosen, because the overall effect of surgery is in the range of about 30 percentage points. Therefore, the minimal clinically relevant difference can be estimated by halving this effect of surgery. To show equivalence for a delta of 15 (SD 18) with alpha = 5% and beta = 20%, a sample size of 60 patients is required [</offsets><xref ref-type="bibr" rid="B22"><offsets xml_i="23003" xml_f="23005" txt_i="16115" txt_f="16117">22</offsets></xref><offsets xml_i="23012" xml_f="23014" txt_i="16117" txt_f="16119">].</offsets></p><p><offsets xml_i="23021" xml_f="23037" txt_i="16120" txt_f="16136">2. The test of H</offsets><sub><offsets xml_i="23042" xml_f="23046" txt_i="16136" txt_f="16140">0,3 </offsets></sub><italic><offsets xml_i="23060" xml_f="23135" txt_i="16140" txt_f="16215">Length of stay on the intensive care unit of both groups is not equivalent </offsets></italic><offsets xml_i="23144" xml_f="23349" txt_i="16215" txt_f="16420">is an equivalent test on the level of 5%. The zero-hypothesis is declined if the 90% confidence interval for the difference of mean values of ICU stay in hours for both groups is in between [-12/12 hours].</offsets></p><p><offsets xml_i="23356" xml_f="23372" txt_i="16421" txt_f="16437">3. The test of H</offsets><sub><offsets xml_i="23377" xml_f="23381" txt_i="16437" txt_f="16441">0,4 </offsets></sub><italic><offsets xml_i="23395" xml_f="23442" txt_i="16441" txt_f="16488">Hospital stay on both groups is not equivalent </offsets></italic><offsets xml_i="23451" xml_f="23647" txt_i="16488" txt_f="16684">is an equivalent test on the level of 5%. The null-hypothesis is declined if the 90% confidence interval for the difference of mean hospital stay in days for both groups is in between [-2/2 days].</offsets></p><p><offsets xml_i="23654" xml_f="23810" txt_i="16685" txt_f="16841">Once the null hypothesis cannot be rejected no further testing is applied. All secondary endpoints will be analyzed using descriptive and graphical methods.</offsets></p><p><offsets xml_i="23817" xml_f="23883" txt_i="16842" txt_f="16908">Safety-related data will be analyzed with respect to frequency of:</offsets></p><p><offsets xml_i="23890" xml_f="23961" txt_i="16909" txt_f="16980">• Severe bleeding intra- or postoperatively requiring blood transfusion</offsets></p><p><offsets xml_i="23968" xml_f="23980" txt_i="16981" txt_f="16993">• Laparotomy</offsets></p><p><offsets xml_i="23987" xml_f="24007" txt_i="16994" txt_f="17014">• Pancreatic fistula</offsets></p><p><offsets xml_i="24014" xml_f="24239" txt_i="17015" txt_f="17240">• Pulmonary infection and wound infection are secondary endpoints, but are also defined as adverse events. Severe intraoperative bleeding with need for blood transfusion will even always be considered a serious adverse event.</offsets></p><p><offsets xml_i="24246" xml_f="24312" txt_i="17241" txt_f="17307">Safety-related data will be analyzed with respect to frequency of:</offsets></p><p><offsets xml_i="24319" xml_f="24404" txt_i="17308" txt_f="17393">• Serious adverse events and adverse events stratified according to the organ-systems</offsets></p><p><offsets xml_i="24411" xml_f="24450" txt_i="17394" txt_f="17433">• Adverse events stratified by severity</offsets></p><p><offsets xml_i="24457" xml_f="24497" txt_i="17434" txt_f="17474">• Adverse events stratified by causality</offsets></p></sec><sec><title><offsets xml_i="24519" xml_f="24537" txt_i="17476" txt_f="17494">Study organisation</offsets></title><p><offsets xml_i="24548" xml_f="24747" txt_i="17495" txt_f="17694">All patients scheduled for duodenum preserving pancreatic head resection at the Department of Surgery, University of Heidelberg, will be referred to the Center for Clinical Studies in Surgery (KSC) [</offsets><xref ref-type="bibr" rid="B23"><offsets xml_i="24779" xml_f="24781" txt_i="17694" txt_f="17696">23</offsets></xref><offsets xml_i="24788" xml_f="25075" txt_i="17696" txt_f="17983">] and screened by members of the KSC. Approximately 80 patients per year undergo a duodenum preserving pancreatic head resection for chronic pancreatitis at the Department of Surgery, University of Heidelberg. The estimated time frame to randomize 65 patients is approximately 18 months.</offsets></p><p><offsets xml_i="25082" xml_f="25314" txt_i="17984" txt_f="18216">Data will be recorded in clinical reporting files. Double data entry will be done by two independent staff members and all analysis are performed with SPSS (SPSS, Chicago, IL) after plausibility controls and closure of the database.</offsets></p></sec><sec><title><offsets xml_i="25336" xml_f="25355" txt_i="18218" txt_f="18237">Competing interests</offsets></title><p><offsets xml_i="25366" xml_f="25426" txt_i="18238" txt_f="18298">The author(s) declare that they have no competing interests.</offsets></p></sec><sec><title><offsets xml_i="25448" xml_f="25470" txt_i="18300" txt_f="18322">Authors' contributions</offsets></title><p><offsets xml_i="25481" xml_f="25922" txt_i="18323" txt_f="18764">J.K. and C.M.S participated in the design and coordination of the study and drafted the manuscript. M.N.W., M.E.R., E.G., and M.W.M. participated in the design and coordination and helped to draft the manuscript. U.M. participated in the statistical design and helped to draft the manuscript. H.F. and M.W.B. conceived the study and supervised the coordination of the study. All authors read and approved the final version of the manuscript.</offsets></p></sec></body><back><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buchler</surname><given-names>MW</given-names></name><name><surname>Friess</surname><given-names>H</given-names></name><name><surname>Muller</surname><given-names>MW</given-names></name><name><surname>Wheatley</surname><given-names>AM</given-names></name><name><surname>Beger</surname><given-names>HG</given-names></name></person-group><article-title>Randomized trial of duodenum-preserving pancreatic head resection versus pylorus-preserving Whipple in chronic pancreatitis</article-title><source>Am J Surg</source><year>1995</year><volume>169</volume><fpage>65</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">7818000</pub-id><pub-id pub-id-type="doi">10.1016/S0002-9610(99)80111-1</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>DB</given-names></name><name><surname>Ford</surname><given-names>MC</given-names></name><name><surname>Anderson</surname><given-names>MC</given-names></name></person-group><article-title>Outcome after lateral pancreaticojejunostomy for chronic pancreatitis</article-title><source>Ann Surg</source><year>1994</year><volume>219</volume><fpage>481</fpage><lpage>487</lpage><pub-id pub-id-type="pmid">8185399</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Greenlee</surname><given-names>HB</given-names></name><name><surname>Prinz</surname><given-names>RA</given-names></name><name><surname>Aranha</surname><given-names>GV</given-names></name></person-group><article-title>Long-term results of side-to-side pancreaticojejunostomy</article-title><source>World J Surg</source><year>1990</year><volume>14</volume><fpage>70</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">2407040</pub-id><pub-id pub-id-type="doi">10.1007/BF01670548</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Izbicki</surname><given-names>JR</given-names></name><name><surname>Bloechle</surname><given-names>C</given-names></name><name><surname>Broering</surname><given-names>DC</given-names></name><name><surname>Knoefel</surname><given-names>WT</given-names></name><name><surname>Kuechler</surname><given-names>T</given-names></name><name><surname>Broelsch</surname><given-names>CE</given-names></name></person-group><article-title>Extended drainage versus resection in surgery for chronic pancreatitis: a prospective randomized trial comparing the longitudinal pancreaticojejunostomy combined with local pancreatic head excision with the pylorus-preserving pancreatoduodenectomy</article-title><source>Ann Surg</source><year>1998</year><volume>228</volume><fpage>771</fpage><lpage>779</lpage><pub-id pub-id-type="pmid">9860476</pub-id><pub-id pub-id-type="doi">10.1097/00000658-199812000-00008</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prinz</surname><given-names>RA</given-names></name><name><surname>Greenlee</surname><given-names>HB</given-names></name></person-group><article-title>Pancreatic duct drainage in 100 patients with chronic pancreatitis</article-title><source>Ann Surg</source><year>1981</year><volume>194</volume><fpage>313</fpage><lpage>320</lpage><pub-id pub-id-type="pmid">7271348</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stapleton</surname><given-names>GN</given-names></name><name><surname>Williamson</surname><given-names>RC</given-names></name></person-group><article-title>Proximal pancreatoduodenectomy for chronic pancreatitis</article-title><source>Br J Surg</source><year>1996</year><volume>83</volume><fpage>1433</fpage><lpage>1440</lpage><pub-id pub-id-type="pmid">8944465</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bockman</surname><given-names>DE</given-names></name><name><surname>Buchler</surname><given-names>MW</given-names></name><name><surname>Malfertheiner</surname><given-names>P</given-names></name><name><surname>Beger</surname><given-names>HG</given-names></name></person-group><article-title>Analysis of nerves in chronic pancreatitis</article-title><source>Gastroenterology</source><year>1988</year><volume>94</volume><fpage>1459</fpage><lpage>1469</lpage><pub-id pub-id-type="pmid">3360267</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nealon</surname><given-names>WH</given-names></name><name><surname>Matin</surname><given-names>S</given-names></name></person-group><article-title>Analysis of surgical success in preventing recurrent acute exacerbations in chronic pancreatitis</article-title><source>Ann Surg</source><year>2001</year><volume>233</volume><fpage></fpage><lpage>800</lpage><pub-id pub-id-type="pmid">11371738</pub-id><pub-id pub-id-type="doi">10.1097/00000658-200106000-00009</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beger</surname><given-names>HG</given-names></name><name><surname>Krautzberger</surname><given-names>W</given-names></name><name><surname>Gogler</surname><given-names>H</given-names></name></person-group><article-title>[Resection of the head of the pancreas (cephalic pancreatectomy) wih conservation of the duodenum in chronic pancreatitis, tumours of the head of the pancreas and compression of the common bile duct (author's transl)]</article-title><source>Chirurgie</source><year>1981</year><volume>107</volume><fpage>597</fpage><lpage>604</lpage><pub-id pub-id-type="pmid">7327022</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beger</surname><given-names>HG</given-names></name><name><surname>Buchler</surname><given-names>M</given-names></name><name><surname>Bittner</surname><given-names>RR</given-names></name><name><surname>Oettinger</surname><given-names>W</given-names></name><name><surname>Roscher</surname><given-names>R</given-names></name></person-group><article-title>Duodenum-preserving resection of the head of the pancreas in severe chronic pancreatitis. Early and late results</article-title><source>Ann Surg</source><year>1989</year><volume>209</volume><fpage>273</fpage><lpage>278</lpage><pub-id pub-id-type="pmid">2923514</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beger</surname><given-names>HG</given-names></name><name><surname>Schlosser</surname><given-names>W</given-names></name><name><surname>Friess</surname><given-names>HM</given-names></name><name><surname>Buchler</surname><given-names>MW</given-names></name></person-group><article-title>Duodenum-preserving head resection in chronic pancreatitis changes the natural course of the disease: a single-center 26-year experience</article-title><source>Ann Surg</source><year>1999</year><volume>230</volume><fpage>512</fpage><lpage>519</lpage><pub-id pub-id-type="pmid">10522721</pub-id><pub-id pub-id-type="doi">10.1097/00000658-199910000-00007</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buchler</surname><given-names>MW</given-names></name><name><surname>Baer</surname><given-names>HU</given-names></name><name><surname>Seiler</surname><given-names>C</given-names></name><name><surname>Reber</surname><given-names>PU</given-names></name><name><surname>Sadowski</surname><given-names>C</given-names></name><name><surname>Friess</surname><given-names>H</given-names></name></person-group><article-title>[Duodenum preserving resection of the head of the pancreas: a standard procedure in chronic pancreatitis]</article-title><source>Chirurg</source><year>1997</year><volume>68</volume><fpage>364</fpage><lpage>368</lpage><pub-id pub-id-type="pmid">9206630</pub-id><pub-id pub-id-type="doi">10.1007/s001040050199</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rattner</surname><given-names>DW</given-names></name><name><surname>Fernandez-del Castillo</surname><given-names>C</given-names></name><name><surname>Warshaw</surname><given-names>AL</given-names></name></person-group><article-title>Pitfalls of distal pancreatectomy for relief of pain in chronic pancreatitis</article-title><source>Am J Surg</source><year>1996</year><volume>171</volume><fpage>142</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">8554129</pub-id><pub-id pub-id-type="doi">10.1016/S0002-9610(99)80089-0</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frey</surname><given-names>CF</given-names></name><name><surname>Smith</surname><given-names>GJ</given-names></name></person-group><article-title>Description and rationale of a new operation for chronic pancreatitis</article-title><source>Pancreas</source><year>1987</year><volume>2</volume><fpage>701</fpage><lpage>707</lpage><pub-id pub-id-type="pmid">3438308</pub-id><pub-id pub-id-type="doi">10.1097/00006676-198711000-00014</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>HS</given-names></name><name><surname>Frey</surname><given-names>CF</given-names></name></person-group><article-title>The Frey procedure: local resection of pancreatic head combined with lateral pancreaticojejunostomy</article-title><source>Arch Surg</source><year>2001</year><volume>136</volume><fpage>1353</fpage><lpage>1358</lpage><pub-id pub-id-type="pmid">11735858</pub-id><pub-id pub-id-type="doi">10.1001/archsurg.136.12.1353</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Izbicki</surname><given-names>JR</given-names></name><name><surname>Bloechle</surname><given-names>C</given-names></name><name><surname>Broering</surname><given-names>DC</given-names></name><name><surname>Kuechler</surname><given-names>T</given-names></name><name><surname>Broelsch</surname><given-names>CE</given-names></name></person-group><article-title>Longitudinal V-shaped excision of the ventral pancreas for small duct disease in severe chronic pancreatitis: prospective evaluation of a new surgical procedure</article-title><source>Ann Surg</source><year>1998</year><volume>227</volume><fpage>213</fpage><lpage>219</lpage><pub-id pub-id-type="pmid">9488519</pub-id><pub-id pub-id-type="doi">10.1097/00000658-199802000-00010</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gloor</surname><given-names>B</given-names></name><name><surname>Friess</surname><given-names>H</given-names></name><name><surname>Uhl</surname><given-names>W</given-names></name><name><surname>Buchler</surname><given-names>MW</given-names></name></person-group><article-title>A modified technique of the Beger and Frey procedure in patients with chronic pancreatitis</article-title><source>Dig Surg</source><year>2001</year><volume>18</volume><fpage>21</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">11244255</pub-id><pub-id pub-id-type="doi">10.1159/000050092</pub-id></citation></ref><ref id="B18"><citation citation-type="other"><ext-link ext-link-type="uri" xlink:href="http://www.klinikum.uni-muenster.de/institute/imib/lehre/skripte/biomathe/bio/bio.html"></ext-link></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aaronson</surname><given-names>NK</given-names></name><name><surname>Ahmedzai</surname><given-names>S</given-names></name><name><surname>Bergman</surname><given-names>B</given-names></name><name><surname>Bullinger</surname><given-names>M</given-names></name><name><surname>Cull</surname><given-names>A</given-names></name><name><surname>Duez</surname><given-names>NJ</given-names></name><name><surname>Filiberti</surname><given-names>A</given-names></name><name><surname>Flechtner</surname><given-names>H</given-names></name><name><surname>Fleishman</surname><given-names>SB</given-names></name><name><surname>de Haes</surname><given-names>JC</given-names></name><name><surname>Kaasa</surname><given-names>S</given-names></name><name><surname>Klee</surname><given-names>M</given-names></name><name><surname>Osoba</surname><given-names>D</given-names></name><name><surname>Razavi</surname><given-names>D</given-names></name><name><surname>Rofe</surname><given-names>PB</given-names></name><name><surname>Schraub</surname><given-names>S</given-names></name><name><surname>Sneeuw</surname><given-names>K</given-names></name><name><surname>Sullivan</surname><given-names>M</given-names></name><name><surname>Takeda</surname><given-names>F</given-names></name></person-group><article-title>The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology</article-title><source>J Natl Cancer Inst</source><year>1993</year><volume>85</volume><fpage>365</fpage><lpage>376</lpage><pub-id pub-id-type="pmid">8433390</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fitzsimmons</surname><given-names>D</given-names></name><name><surname>Johnson</surname><given-names>CD</given-names></name><name><surname>George</surname><given-names>S</given-names></name><name><surname>Payne</surname><given-names>S</given-names></name><name><surname>Sandberg</surname><given-names>AA</given-names></name><name><surname>Bassi</surname><given-names>C</given-names></name><name><surname>Beger</surname><given-names>HG</given-names></name><name><surname>Birk</surname><given-names>D</given-names></name><name><surname>Buchler</surname><given-names>MW</given-names></name><name><surname>Dervenis</surname><given-names>C</given-names></name><name><surname>Fernandez Cruz</surname><given-names>L</given-names></name><name><surname>Friess</surname><given-names>H</given-names></name><name><surname>Grahm</surname><given-names>AL</given-names></name><name><surname>Jeekel</surname><given-names>J</given-names></name><name><surname>Laugier</surname><given-names>R</given-names></name><name><surname>Meyer</surname><given-names>D</given-names></name><name><surname>Singer</surname><given-names>MW</given-names></name><name><surname>Tihanyi</surname><given-names>T</given-names></name></person-group><article-title>Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life</article-title><source>Eur J Cancer</source><year>1999</year><volume>35</volume><fpage>939</fpage><lpage>941</lpage><pub-id pub-id-type="pmid">10533475</pub-id><pub-id pub-id-type="doi">10.1016/S0959-8049(99)00047-7</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Begg</surname><given-names>C</given-names></name><name><surname>Cho</surname><given-names>M</given-names></name><name><surname>Eastwood</surname><given-names>S</given-names></name><name><surname>Horton</surname><given-names>R</given-names></name><name><surname>Moher</surname><given-names>D</given-names></name><name><surname>Olkin</surname><given-names>I</given-names></name><name><surname>Pitkin</surname><given-names>R</given-names></name><name><surname>Rennie</surname><given-names>D</given-names></name><name><surname>Schulz</surname><given-names>KF</given-names></name><name><surname>Simel</surname><given-names>D</given-names></name><name><surname>Stroup</surname><given-names>DF</given-names></name></person-group><article-title>Improving the quality of reporting of randomized controlled trials. The CONSORT statement</article-title><source>JAMA</source><year>1996</year><volume>276</volume><fpage>637</fpage><lpage>639</lpage><pub-id pub-id-type="pmid">8773637</pub-id><pub-id pub-id-type="doi">10.1001/jama.276.8.637</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>B</given-names></name><name><surname>Jarvis</surname><given-names>P</given-names></name><name><surname>Lewis</surname><given-names>JA</given-names></name><name><surname>Ebbutt</surname><given-names>AF</given-names></name></person-group><article-title>Trials to assess equivalence: the importance of rigorous methods</article-title><source>BMJ</source><year>1996</year><volume>31</volume><fpage>36</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">8664772</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seiler</surname><given-names>CM</given-names></name><name><surname>Wente</surname><given-names>MN</given-names></name><name><surname>Diener</surname><given-names>MK</given-names></name><name><surname>Frohlich</surname><given-names>BE</given-names></name><name><surname>Buchler</surname><given-names>MW</given-names></name><name><surname>Knaebel</surname><given-names>HP</given-names></name></person-group><article-title>Center for clinical studies in a surgical department-An approach for more evidence-based medicine</article-title><source>Contemp Clin Trials</source><year>2005</year><volume>27</volume><comment>Epub ahead of print</comment><pub-id pub-id-type="pmid">16316788</pub-id></citation></ref></ref-list></back></article>